AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Sales of Adderall XR to resume.(NEWS NOTES)(Brief Article)
Health Canada has announced it will allow Shire Pharmaceuticals to resume sales of Adderall XR[R], a central nervous system stimulant approved in January 2004 for the treatment of attention deficit hyperactivity disorder (ADHD). A February 2005 suspension was a response to safety data indicating possible sudden deaths, heart-related deaths and strokes in children and adults taking the drug. (The immediate release version of the drug has never been marketed in Canada.) Under the Food and Drug Regulations act, Shire was permitted to appoint an independent committee to review Health Canada's decision. The New …
-
- Shire Pharmaceuticals Group Plc regulatory approval received for Adderall XR...
-
News wire article from: Asia Africa Intelligence Wire
February 3, 2004
700+ words
-
- Shire Pharmaceuticals announces reinstatement of Adderall XR in Canada.
-
News wire article from: Asia Africa Intelligence Wire
August 24, 2005
700+ words
-
- Shire announces suspension of Adderall XR sales in Canada.
-
News wire article from: Asia Africa Intelligence Wire
February 10, 2005
700+ words
-
- Health Canada suspends Adderall.
-
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update
Kratochvil, Christopher J.
March 1, 2005
700+ words
-
- Health Canada suspends Adderall.(News Notes)(Attention Deficit Hyperactivity...
-
Magazine article from: Brown University Psychopharmacology Update
April 1, 2005
700+ words
